NK T-CELL LYMPHOMA

Clinical trials for NK T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NK T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for NK T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 4 Not yet finished but already full! 2 Completed 1 Terminated 1

Engineered immune cells take on Hard-to-Treat lymphoma

Disease control Recruiting now

This early-phase trial tests a personalized cell therapy for people with a specific type of lymphoma linked to the Epstein-Barr virus (EBV). The treatment uses the patient's own immune cells, modified to recognize and attack EBV-infected cancer cells. The study aims to find a saf…

Matched conditions: NK T-CELL LYMPHOMA

Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated May 11, 2026 20:53 UTC

NK T-CELL LYMPHOMA

Get alerted when new NK T-CELL LYMPHOMA trials appear

Engineered immune cells take on Hard-to-Treat lymphoma